DISEASE: CONGESTIVE HEART FAILURE For this assignment, you will write a paper on the pharmacological management of the disease. The paper should in

DISEASE: CONGESTIVE HEART FAILURE

For this assignment, you will write a paper on the pharmacological management of the disease. The paper should include a review of the:

· Select a disease process that is of interest to you.

· Pathophysiology of the disease state.

· Review of the pharmacological agents used for treatment and important information related to advanced practice nurse.

· Each student will clearly write a title for this topic: For examples, “Pharmacological Effects of Anti-Hypertensive Medications in the Management of Hypertension”.

 

Submission Instructions:

· The paper is to be clear and concise and students will lose points for improper grammar, punctuation, and misspelling.

· The paper should be formatted per the current APA and 5-7 pages in length, excluding the title, abstract and references page.

· This assignment will be assessed through Turnitin.

· Incorporate a minimum of 5 current (published within the last five years) scholarly journal articles within your work.

image1.png

Share This Post

Email
WhatsApp
Facebook
Twitter
LinkedIn
Pinterest
Reddit

Order a Similar Paper and get 15% Discount on your First Order

Related Questions

  Read “M2 Dimick Sorting out Advance Directives_Journal of AHIMA HL.pdf” attached above. You are a Medical Records Technician at Northwestern Memorial

  Read “M2 Dimick Sorting out Advance Directives_Journal of AHIMA HL.pdf” attached above. You are a Medical Records Technician at Northwestern Memorial Hospital.  One of your tasks is applying applicable laws, policies, and procedures for ROI. For each scenario, describe the decision you render.  Answer the two questions that follow.

As a psychiatric mental health nurse practitioner (PMHNP), how do you approach the management of treatment-resistant schizophrenia, particularly in

As a psychiatric mental health nurse practitioner (PMHNP), how do you approach the management of treatment-resistant schizophrenia, particularly in cases where traditional antipsychotic medications and psychosocial interventions have been ineffective? What are the challenges and opportunities in utilizing biomarkers of inflammation to aid in the early diagnosis and personalized treatment